1. Home
  2. ZVSA vs NITO Comparison

ZVSA vs NITO Comparison

Compare ZVSA & NITO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZVSA
  • NITO
  • Stock Information
  • Founded
  • ZVSA 2014
  • NITO 2009
  • Country
  • ZVSA United States
  • NITO Israel
  • Employees
  • ZVSA N/A
  • NITO N/A
  • Industry
  • ZVSA Biotechnology: Pharmaceutical Preparations
  • NITO
  • Sector
  • ZVSA Health Care
  • NITO
  • Exchange
  • ZVSA Nasdaq
  • NITO NYSE
  • Market Cap
  • ZVSA 2.5M
  • NITO 2.2M
  • IPO Year
  • ZVSA N/A
  • NITO N/A
  • Fundamental
  • Price
  • ZVSA $1.49
  • NITO $1.20
  • Analyst Decision
  • ZVSA Strong Buy
  • NITO
  • Analyst Count
  • ZVSA 1
  • NITO 0
  • Target Price
  • ZVSA $240.00
  • NITO N/A
  • AVG Volume (30 Days)
  • ZVSA 2.1M
  • NITO 55.2M
  • Earning Date
  • ZVSA 11-14-2024
  • NITO 11-14-2024
  • Dividend Yield
  • ZVSA N/A
  • NITO N/A
  • EPS Growth
  • ZVSA N/A
  • NITO N/A
  • EPS
  • ZVSA N/A
  • NITO N/A
  • Revenue
  • ZVSA N/A
  • NITO $175,308.00
  • Revenue This Year
  • ZVSA N/A
  • NITO N/A
  • Revenue Next Year
  • ZVSA N/A
  • NITO N/A
  • P/E Ratio
  • ZVSA N/A
  • NITO N/A
  • Revenue Growth
  • ZVSA N/A
  • NITO N/A
  • 52 Week Low
  • ZVSA $0.98
  • NITO $0.16
  • 52 Week High
  • ZVSA $25.00
  • NITO $3.49
  • Technical
  • Relative Strength Index (RSI)
  • ZVSA 61.69
  • NITO 55.65
  • Support Level
  • ZVSA $1.25
  • NITO $1.16
  • Resistance Level
  • ZVSA $1.95
  • NITO $2.70
  • Average True Range (ATR)
  • ZVSA 0.17
  • NITO 0.44
  • MACD
  • ZVSA 0.05
  • NITO 0.06
  • Stochastic Oscillator
  • ZVSA 51.58
  • NITO 30.92

About ZVSA ZyVersa Therapeutics Inc.

ZyVersa Therapeutics Inc is a clinical-stage biopharmaceutical company leveraging proprietary technologies to develop drugs for patients with chronic renal or inflammatory diseases with high unmet medical needs. The company has two proprietary globally licensed drug development platforms which are Cholesterol Efflux MediatorTM, VAR 200 (2-hydroxypropyl-beta-cyclodextrin) is an injectable drug in clinical development for the treatment of renal diseases. and IC 100 is a monoclonal antibody inflammasome ASC inhibitor in preclinical development for the treatment of inflammatory conditions.

About NITO N2OFF INC

N2OFF Inc is a pioneering agri-food tech company dedicated to developing sustainable solutions for the plant-based food industry. Operating through two subsidiaries, it delivers integrated solutions for enhanced safety, quality, and sustainability from field to fork.

Share on Social Networks: